Evidence method
Level · gp.fundamentals.debt_to_revenue
420.29% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
GH · Sep 30, 2025
Guardant Health, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001576280-25-000277General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.90% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.35% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
38.50% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
34.12% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
64.71% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-37.33% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
33.92% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
16.14% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History22 statesSelf-history eligible
Sep 30, 20210/7 normalizedLevel 3Dec 31, 20210/7 normalizedLevel 3Mar 31, 20226/7 normalizedLevel 3Jun 30, 20226/7 normalizedLevel 3Sep 30, 20226/7 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20237/7 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20237/7 normalizedLevel 3Mar 31, 20247/7 normalizedLevel 3Jun 30, 20247/7 normalizedLevel 3Sep 30, 20247/7 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/9 normalizedLevel 3Jun 30, 20257/9 normalizedLevel 3Sep 30, 20257/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 480.65%
- Current
- 420.29%
- Delta
- -60.36%
- Previous
- 2.43%
- Current
- 3.90%
- Delta
- 1.47%
- Previous
- -25.98%
- Current
- -13.35%
- Delta
- 12.62%
- Previous
- 30.95%
- Current
- 38.50%
- Delta
- 7.55%
- Previous
- 36.22%
- Current
- 34.12%
- Delta
- -2.10%
- Previous
- 65.01%
- Current
- 64.71%
- Delta
- -0.30%
- Previous
- -45.85%
- Current
- -37.33%
- Delta
- 8.52%
- Previous
- 37.68%
- Current
- 33.92%
- Delta
- -3.76%
- Previous
- 18.30%
- Current
- 16.14%
- Delta
- -2.15%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · GH Fundamental State →Analogous To · GH state analogue 1 →Has State · Guardant Health, Inc. →Transitioned To · GH Fundamental State →Transitioned To · GH BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · GH CAPEX_INTENSITY_INCREASED →Transitioned To · GH CASH_GENERATION_INCREASED →Transitioned To · GH GROWTH_INCREASED →Transitioned To · GH INVENTORY_PRESSURE_DECREASED →Transitioned To · GH MARGIN_DECREASED →Transitioned To · GH PROFITABILITY_INCREASED →Transitioned To · GH R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.